Search - tctmd.com

Displaying 181 - 200 of 222

Sort: Relevancy | Date

News Conference News ACC 2018

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

Michael O'Riordan

March 10, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Conference News CRT 2018

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Michael O'Riordan

March 08, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

News Daily News

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

Yael L. Maxwell

March 08, 2018

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

News Daily News

Cardiology Research Roadblock: Female First Authors on the Rise, but Senior Names Have Stayed Male

Shelley Wood

February 23, 2018

News Daily News

Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF

Todd Neale

February 20, 2018

News Daily News

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

Michael O'Riordan

February 09, 2018

News Daily News

Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke

Michael O'Riordan

February 07, 2018

News Conference News ISET 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Caitlin E. Cox

February 07, 2018

News Daily News

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

Yael L. Maxwell

February 06, 2018

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

News Daily News

Sodium Fluoride Imaging in AAAs Provides a Picture of Future Risk

Caitlin E. Cox

January 30, 2018

News Daily News

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Yael L. Maxwell

January 24, 2018

Advertisement

ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol

Less Aggressive HbA1c Targets Recommended by American College of Physicians

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Cardiology Research Roadblock: Female First Authors on the Rise, but Senior Names Have Stayed Male

Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

CABG Results in Better Long-term Outcomes Than PCI for Younger Patients With Three-Vessel Disease

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

SELUTION™ First-in-Man Study Achieves Primary Endpoint

Sodium Fluoride Imaging in AAAs Provides a Picture of Future Risk

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content